Full text is available at the source.
Abstract
Rhein treatment reduced infarct volume and blood-brain barrier disruption in a rat model of ischemic stroke.
- Rhein demonstrated dose-dependent neuroprotective effects against ischemia/reperfusion injury.
- Treatment with Rhein suppressed oxidative stress and reduced the generation of reactive oxygen species in both in vivo and in vitro models.
- Rhein inhibited the expression of proteins associated with ferroptosis, a form of regulated cell death.
- The protective mechanism of Rhein involved the NRF2/SLC7A11/GPX4 signaling pathway, with NRF2 inhibition negating its neuroprotective effects.
- Molecular analyses indicated a direct interaction between Rhein and the ferroptosis-related protein NRF2.
Simplified
BACKGROUND: Ischemic stroke, a major cause of death and disability worldwide, results from reduced blood flow to the brain, leading to irreversible neuronal damage. Recent evidence suggests that ferroptosis, a form of regulated cell death, plays a critical role in the pathogenesis of ischemic stroke. Rhein, a natural anthraquinone compound, has demonstrated neuroprotective effects; However, its role in ferroptosis and the underlying mechanisms remain unclear. Here, we investigated the protective effects of Rhein against ischemia/reperfusion (I/R) injury in a rat model of middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation/reperfusion (OGD/R)-induced HT22 cells. Rhein treatment dose-dependently ameliorated neurological deficits, reduced infarct volume, and attenuated blood-brain barrier (BBB) disruption in the MCAO model. Furthermore, Rhein suppressed oxidative stress, intracellular ROS generation, and ferroptosis-related protein expression in both in vivo and in vitro models. Mechanistically, Rhein protected against OGD/R-induced HT22 cell injury by regulating the NRF2/SLC7A11/GPX4 signaling pathway. This effect was abolished upon NRF2 inhibition, suggesting that Rhein's neuroprotective action is NRF2-dependent. Molecular docking and microscale thermophoresis analyses further supported the direct interaction between Rhein and the ferroptosis-related protein NRF2. Collectively, our findings reveal that Rhein confers neuroprotection against cerebral I/R injury by inhibiting ferroptosis via the NRF2/SLC7A11/GPX4 axis, providing a potential therapeutic avenue for ischemic stroke.
AIMS: To investigate the neuroprotective effects of Rhein, a natural anthraquinone compound, against ischemia/reperfusion (I/R) injury and elucidate the underlying mechanisms involving ferroptosis and the NRF2/SLC7A11/GPX4 pathway.
METHODS: A rat model of middle cerebral artery occlusion (MCAO) was employed for in vivo assessments, while oxygen-glucose deprivation/reperfusion (OGD/R)-induced HT22 cells were used as an in vitro model. Comprehensive analyses, including neurological score assessment, triphenyl tetrazolium chloride staining, Evans Blue leakage assay, intracellular ROS detection, MTT assay, dual-luciferase reporter assay, oxidative stress and Fecontent assessment, immunofluorescence, Western blot, flow cytometry, molecular docking, and microscale thermophoresis, were performed to evaluate the effects of Rhein on I/R injury and ferroptosis. 2+
RESULTS: Rhein conferred dose-dependent neuroprotection against cerebral I/R injury, reducing infarct volume and blood-brain barrier (BBB) disruption in the MCAO model. In both in vivo and in vitro models, Rhein suppressed oxidative stress, intracellular ROS generation, and ferroptosis-related protein expression. Furthermore, Rhein protected HT22 cells from OGD/R-induced injury by regulating the NRF2/SLC7A11/GPX4 signaling pathway, with NRF2 inhibition abolishing these therapeutic effects. Molecular docking and microscale thermophoresis analyses supported a direct interaction between Rhein and NRF2, a ferroptosis-related protein.
CONCLUSION: Rhein attenuates cerebral I/R injury by inhibiting ferroptosis via the NRF2/SLC7A11/GPX4 axis, highlighting its potential as a therapeutic agent for ischemic stroke.
Related papers
Mar '23
Loureirin C may reduce brain cell death after stroke by activating the brain's protective Nrf2 pathway in mice
top 10% journal
cited by 60 papers
journal article
May '22
β-Caryophyllene may reduce brain cell death caused by stroke-related injury through activating a protective cell pathway in rats
top 10% journal
cited by 154 papers
journal article
Apr '24
N6022 reduces brain injury after blood flow returns by protecting immune cells through boosting antioxidant defense and blocking harmful pathways
top 20% journal
cited by 19 papers
journal article
Aug '24
Oltipraz reduced brain damage after blood flow loss and return by lowering oxidative stress and cell death in mice
cited by 11 papers
journal article
Jul '23
Activin A may protect mouse brain cells from stroke damage by boosting a cell defense protein to reduce iron-related cell death
top 20% journal
cited by 17 papers
research support, non-u.s. gov't
Nov '23
Nrf2 reduces oxidative stress to help ciprofol protect the brain from blood flow injury
top 30% journal
cited by 20 papers
journal article
Jan '22
Rehmannioside A may improve memory loss and reduce cell death by activating protective cell pathways after blood flow loss
top 20% journal
cited by 311 papers
journal article
Feb '18
Isoquercetin reduces cell damage and nerve cell death after blood flow loss and return by activating protective cell defense pathways
top 20% journal
cited by 162 papers
journal article
Jan '24
Ozone’s brain protection may involve cell death control through the NRF2/SLC7A11/GPX4 pathway
top 30% journal
cited by 16 papers
journal article
Oct '23
Caffeic acid reduces brain damage after stroke in rats by preventing cell death through the Nrf2 protective pathway
top 5% journal
cited by 76 papers
journal article